Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze DVAX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DVAX investment potential.

What is DVAX stock price today?

Get real-time DVAX stock price, historical data, and price charts on Financhill. Track DVAX performance with our advanced analysis tools.

Is DVAX a good investment?

Evaluate DVAX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy DVAX stock?

To buy DVAX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DVAX?

View detailed market capitalization data and company valuation metrics for DVAX on our comprehensive analysis page.

What is the P/E ratio of DVAX?

Use our fundamental analysis tools to view DVAX P/E ratio and compare valuation metrics with industry peers.

What are DVAX earnings?

View DVAX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Dynavax Technologies Corp. 10K Form

Buy

DVAX
Dynavax Technologies Corp.

Last Price:

$10.89

Seasonality Move:

10.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08	10Q	DVAX/Dynavax Technologies Corp. Quarterly
2023-11-02	10Q	DVAX/Dynavax Technologies Corp. Quarterly
2023-08-03	10Q	DVAX/Dynavax Technologies Corp. Quarterly
2023-05-02	10Q	DVAX/Dynavax Technologies Corp. Quarterly
2022-11-03	10Q	DVAX/Dynavax Technologies Corp. Quarterly
2022-08-04	10Q	DVAX/Dynavax Technologies Corp. Quarterly

Receive DVAX News And Ratings

See the #1 stock for the next 7 days that we like better than DVAX

DVAX Financial Statistics

Sales & Book Value

Annual Sales:	$277.2M
Cash Flow:	$32.6M
Price / Cash Flow:	18.68
Annual Sales:	$4.55
Price / Book:	2.39

Profitability

EPS (TTM):	-0.38190
Net Income (TTM):	$-43.4M
Gross Margin:	$227.8M
Return on Equity:	-7.65%
Return on Assets:	-4.47%

Dynavax Technologies Corp. Earnings Forecast

Key Dynavax Technologies Corp. Financial Ratios

The Gross Profit Margin over the past 26 years for DVAX is 82.17%.
The Selling, General & Administrative Expenses for DVAX have been equal to 61.45% of Gross Profit Margin.
The Research & Development expenses have been 22.20% of Revenue.
The Interest Expense is 24.88% of Operating Income.
The Net Earning history of DVAX is 9.85% of Total Revenues.
Per Share Earnings over the last 26 years have been positive in 17 years.

Dynavax Technologies Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	DVAX
CUSIP:	268158
Website:	dynavax.com

Debt

Debt-to-Equity Ratio:	0.54
Current Ratio:	7.62
Quick Ratio:	6.74

Price-to-Earnings

Trailing P/E Ratio:	53.17
Forward P/E Ratio:	33

DVAX Technical Analysis vs Fundamental Analysis

Buy

Dynavax Technologies Corp. (DVAX) is a Buy

Is Dynavax Technologies Corp. a Buy or a Sell?

Dynavax Technologies Corp. stock is rated a Buy

The current Dynavax Technologies Corp. [DVAX] share price is $10.89. The Score for DVAX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.